Intel Foundry Secures Terafab AI Deal and Repurchases Ireland Fab for $14.2B
Intel has turned its Foundry segment—which posted a $7 billion operating loss in 2023—into commercial 18A node production with marquee contracts such as Musk’s Terafab AI chips for Tesla and xAI. CHIPS Act funding delivers $8.5 billion in grants and $11 billion in loans, and Intel repurchased its Ireland fab stake for $14.2 billion.
1. Foundry Turnaround and Production
Intel committed over $100 billion to rebuild its U.S. manufacturing base, but Foundry posted operating losses of approximately $7 billion in 2023 and further losses through 2024–2025. Recent quarters saw the launch of 18A process in commercial production, marking a pivotal shift toward profitability.
2. Marquee Customer Partnerships
Elon Musk’s Terafab project selected Intel Foundry to supply AI chips for Tesla’s robotics program and xAI data centers, demonstrating confidence in production readiness and establishing Intel as a credible external foundry partner.
3. Financial Backing and Fab Repurchase
Intel secured $8.5 billion in CHIPS Act grants and access to $11 billion in government loans for its Arizona and Ohio fabs, reducing capital risk. The company also repurchased the 49% stake in its Ireland fab for $14.2 billion, signaling peak cash consumption is likely past.
4. Stock Performance and Strategic Position
Intel stock has nearly tripled over the past year as markets revalue the Foundry segment from loss-making manufacturer to strategic U.S. infrastructure asset. Persistent U.S.–China tensions enhance the strategic importance of domestic advanced chip production with no viable alternatives.